NYSE:LMND 5 November 2025 - 6 July 2026

Lemonade, Inc. heads into the weekend with investors recalibrating after a sharp down day that interrupted the insurtech stock’s powerful 2025 run. LMND finished Friday’s regular session at $74.69, down 6.40%, after trading as low as $73.80. In the final minutes of extended trading, shares were $74.10 at 7:59 PM ET, according to Stock Analysis data. StockAnalysis

Lemonade ripped higher on Wednesday after posting stronger‑than‑expected Q3 2025 results and lifting its full‑year outlook, with investors cheering evidence of faster growth and improving underwriting quality.

On Nov. 5, 2025 after market-close, Lemonade released its Q3 financials, and the stock surged. Both press coverage and company statements highlighted robust top-line growth and improving loss metrics. For example, Investing.com reported revenue +42% YOY to $194.5M and a narrower-than-forecast loss of $0.51 per shareau.investing.com. It noted in-force premium up 30% YOY to $1.16B – an eighth consecutive quarter of accelerating growthau.investing.com. The CEO, Daniel Schreiber, said: “In Q3, we continued both our growth acceleration — crossing 30% IFP growth ahead of schedule — and our steady progress toward profitability.”investorshub.advfn.com.